Plante Moran Financial Advisors »

Lineage Cell Therapeutics In shares owned by Plante Moran Financial Advisors

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Plante Moran Financial Advisors from 13F filings

Historical chart of Plante Moran Financial Advisors investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Plante Moran Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Plante Moran Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $3 2 1.50
2023-12-31 $2 2 1.00

More positions owned by Plante Moran Financial Advisors

Vanguard S&p 500 Etf Etf (VOO)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Extended Market Etf Etf (VXF)
Ishares National Muni Bond Etf Etf (MUB)
Vanguard Large-cap Etf Etf (VV)
Spdr Portfolio Developed World Ex-us Etf Etf (SPDW)
Spdr S&p 500 Etf Trust Etf (SPY)
Vanguard Small Cap Value Etf Etf (VBR)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Pepsico Stock (PEP)
Ishares Core S&p 500 Etf Etf (IVV)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Vanguard Total Stock Market Etf Etf (VTI)
Nvidia Corporation Stock (NVDA)

View all positions for Plante Moran Financial Advisors

Top funds holding Lineage Cell Therapeutics In

BlackRock
Vanguard Group
Defender Capital
Geode Capital Management
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Nuveen Asset Management
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Connor, Clark & Lunn Investment Management

View all funds holding Lineage Cell Therapeutics In